JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Kadmon Announces Pricing of Initial Public Offering
-
Triangle Capital (TCAP) Prices 6.25M Common Stock Offering at $19.90/Share
-
Triangle Capital Corporation Announces Pricing of Public Offering of Common Stock
-
JMP Group to Report Second Quarter Financial Results on July 27, 2016
-
Triangle Capital (TCAP) Announces 6.25M Share Common Stock Offering
-
Triangle Capital Corporation Announces Commencement of Public Offering of Common Stock
-
JMP Securities Starts Syros Pharmaceuticals (SYRS) at Market Outperform
-
JMP Securities Starts Bluerock Residential Growth REIT (BRG) at Market Outperform
-
JMP Group Declares Third Quarter 2016 Monthly Distributions
-
Yahoo reports lackluster results as sale looms
-
Notable Analyst Rating Changes 7/18: (FMSA) (HUM) (GRPN) Upgraded; (I) (MCUR) (CTL) Downgraded
-
JMP Securities Starts Twilio (TWLO) at Market Perform
-
JMP Securities Downgrades American Campus Communities (ACC) to Market Perform
-
Alexandria Real Estate Equities, Inc. Announces Closing Of Public Offering Of 7,475,000 Shares Of Common Stock Including Exercise In Full Of Underwriters' Option To Purchase Additional Shares
-
Revionics Expands its Retailer Footprint in Latin America with the Addition of Drogaria Araujo
-
Notable Analyst Rating Changes 7/7: (GLW) (ACHN) (MRO) Upgraded; (CHNI) (DEPO) (YUME) Downgraded
-
Alexandria Real Estate's (ARE) 6.5M Common Stock Offering Prices at $101/Share
-
Alexandria Real Estate Equities, Inc. Announces Pricing Of Public Offering Of 6,500,000 Shares Of Common Stock
-
JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
-
Ashford Trust Prices Public Offering Of Preferred Stock
-
Syros Pharmaceuticals Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
-
NHI to Attend the JMP Securities Boston Real Estate Event
-
JMP Securities Downgrades Medical Properties Trust (MPW) to Market Perform
-
Syros Pharmaceuticals (SYRS) IPO Opens Up 20%
-
LTC Senior Management to Participate at the JMP Securities Boston Real Estate Event
-
JMP Securities Resumes AtriCure Inc. (ATRC) at Market Outperform
-
Syros Pharmaceuticals (SYRS) Prices 4M Common Stock IPO at $12.50/Share, Under Expected Range
-
Syros Pharmaceuticals Announces Pricing of Initial Public Offering
-
Hercules Announces the Second Closing of its 6.25% Notes Due 2024 Offering of $60.0 Million
-
JMP Securities Starts Argo Group International (AGII) at Market Perform
-
Sabra Health Care REIT, Inc. Participating in the JMP Securities Boston Real Estate Event
-
Twilio (TWLO) IPO Opens Up 60%
-
Twilio (TWLO) Prices 10M Common Stock IPO at $15/Share, Above Expected Range
-
Hercules Prices an Additional $60.0 Million of 6.25% Notes Due 2024
-
Twilio Announces Pricing of Initial Public Offering
-
JMP Securities Downgrades Qlik Technologies (QLIK) to Market Perform
-
Notable Analyst Rating Changes 6/22: (GFI) (ENLK) (WEN) Upgraded; (HR) (PZZA) (MGP) Downgraded
-
Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
-
JMP Securities Downgrades Healthcare Realty Trust (HR) to Market Underperform
-
JMP Securities Downgrades Physicians Realty Trust (DOC) to Market Perform
-
Medgenics (MDGN) Prices 3.64M Common Stock Offering at $5.50/Share
-
SteadyMed to Present at the 2016 JMP Securities Life Sciences Conference
-
Medgenics Announces Pricing of Public Offering of Common Stock
-
Summit Hotel Properties Prices Public Offering Of 6.45% Series D Cumulative Redeemable Preferred Stock
-
Teligent, Inc. To Present At JMP Securities Life Sciences Conference On June 21, 2016
-
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Immune Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016
-
Intrexon to Present at the JMP Securities Life Sciences Conference
-
Mainstay Medical to Present at the 2016 JMP Securities Life Sciences Conference
-
OvaScience to Present at the JMP Securities Life Sciences Conference

